The authors of the study, published in Cell Reports Medicine, are optimistic that it could pave the way for potential ...

January 10, 2026 - PRESSADVANTAGE - Chiropractor Evansville has released an announcement outlining its approach to ...

Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of hematopoietic ...

(RTTNews) - Omeros Corporation (OMER) today announced that the FDA has approved YARTEMLEA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy in adults and ...

Omeros has won U.S. Food and Drug Administration approval of its Yartemlea treatment for an often-fatal complication of stem-cell transplants. Omeros on Wednesday said the approval covers Yartemlea ...

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of hematopoietic stem cell ...

ABSTRACT: Food quality is one of the most important factors influencing animals’ immunity. In the present study, Siberian hamsters (Phodopus sungorus) were used to understand the effect of feeding ...

Have you ever found yourself wrestling with Excel formulas, trying to extract the right data from a massive spreadsheet, only to end up frustrated by errors or limitations? If so, you’re not alone.

Mirima Freimer, MD, delves into potential reasons behind the longer-term efficacy of zilucoplan and also speaks to the treatment’s safety profile. Freimer was an author on 5 abstracts presented at the ...